By | July 14, 2014

New FDA Warning Against Use of Numbing Medications in Infants

Parents with teething infants should not use “gum-numbing” anesthetics known as viscous lidocaine, the U.S. Food and Drug Administration (FDA) recently reported. When used among infants and young children, such medications can… Read More

By | June 23, 2014

New Risk of Blood Clots Associated with Testosterone Treatments

The US Food and Drug Administration (FDA), announced last week that there has been another risk associated with testosterone treatments. The FDA is now requiring manufacturers of testosterone or low T products must… Read More

By | June 11, 2014

Testosterone Therapy Lawsuits Consolidated Before One Judge

The U.S. Judicial Panel on Multidistrict Litigation has ordered the consolidation of all federal testosterone therapy lawsuits before the Hon. Matthew F. Kennelly in the Northern District of Illinois, U.S. District Court.… Read More

By | June 10, 2014

Testosterone Therapy Lawsuits Consolidated Before One Judge

The U.S. Judicial Panel on Multidistrict Litigation has ordered the consolidation of all federal testosterone therapy lawsuits before the Hon. Matthew F. Kennelly in the Northern District of Illinois, U.S. District Court.… Read More

By | May 7, 2014

FDA Moves Transvaginal Mesh Devices to ‘High Risk’ Category

The U.S. Food and Drug Administration recently submitted a federal proposal to establish stricter safety requirements for transvaginal surgical mesh implants. The devices are often used to repair pelvic collapse in women, and… Read More

By | April 22, 2014

The Psychological Effects of Gynecomastia Linked to Risperdal

A study conducted by the American Society of Plastic Surgeons (ASPS) and colleagues of Boston Children’s Hospital examined the mental and emotional effects of gynecomastia, a condition in which men develop female… Read More

By | April 16, 2014

Low Testosterone Diagnosis: Are Current Testing Methods Substantial?

Since 2000, the number of American men taking testosterone replacement therapy has quadrupled. More than 5 million prescriptions were written for testosterone therapy in 2011 alone.  Men experience a decline in natural… Read More

By | April 16, 2014

Louisiana Jury Orders Actos Manufacturer to Pay $9 Billion

Takeda Pharmaceutical Co. and Eli Lilly & Co. have been ordered to pay a total of $9 billion in punitive damages in connection to the diabetes drug Actos. A Louisiana jury found… Read More

By | March 14, 2014

Consolidation of Lipitor Lawsuits to Streamline Process

Currently 56 personal injury claims regarding Lipitor have been filed. More than 170 similar federal cases are pending in more than 40 districts before 100 different judges. As a result, the U.S.… Read More

By | March 7, 2014

FDA Runs First Widespread Quality & Safety Evaluation on Generic Drugs

More than 80 percent of prescription drugs in the U.S. are being tested by the Food and Drug Administration (FDA) in its first widespread safety and quality evaluation. The effort will examine… Read More

Topics

PAST ARTICLES